Nanobioanálisis
NBA


Universidad de Navarra
Pamplona, EspañaPublications in collaboration with researchers from Universidad de Navarra (8)
2023
-
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients
Haematologica, Vol. 108, Núm. 10, pp. 2753-2763
2022
-
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 9, pp. e844-e852
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2021
-
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420
1991
-
Protection against the lethal effect and arthritogenic capacity of Yersinia enterocolitica serovar O: 3 for mice
FEMS Microbiology Letters, Vol. 76, Núm. 5, pp. 289-297
1986
-
Analysis by coagglutination of the distribution of a 24,000-dalton surface protein in Yersinia isolates
Journal of Clinical Microbiology, Vol. 23, Núm. 4, pp. 804-805
1985
-
Characterization of a Yersinia enterocolitica antigen common to enterocolitis-associated serotypes
Journal of Clinical Microbiology, Vol. 22, Núm. 6, pp. 1035-1039
1982
-
Immunological identity of Brucella native hapten, polysaccharide B, and Yersinia enterocolitica serotype 9 native hapten
Infection and Immunity, Vol. 38, Núm. 2, pp. 778-780